The calcium‐sensing receptor: A novel target for treatment and prophylaxis of neratinib‐induced diarrhea

• Κύριοι συγγραφείς: Taras Lysyy (Συγγραφέας), Alshad S. Lalani (Συγγραφέας), Elizabeth A. Olek (Συγγραφέας), Irmina Diala (Συγγραφέας), John P. Geibel (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wiley, 2019-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Diarrhea is one of the most commonly reported adverse effect of hemotherapy and targeted cancer therapies, such as tyrosine kinase inhibitors (TKI), which often significantly impact patient quality of life, morbidity, and mortality. Neratinib is an oral, irreversible pan‐HER tyrosine kinase...